Rising antibiotic resistance rates in Ukraine show that AMR is not a regional issue. The threat of AMR, both medically and economically, is increasing worldwide.
#AMR#AMRpolicy#antimicrobialresistance
https://t.co/mBhUuRN8VU
This article dives into the emerging field of digital antibiotic discovery, and it's potential to combat antimicrobial resistance.
#AMR#AntimicrobialResistance
https://t.co/IGBxlHkau5
Phage therapy has come a long way since Western Countries dropped the treatment after the discovery of penicillin.
#AMR#AntimicrobialResistance
https://t.co/GXrJFHIX2G
Bacteriophage, or phage, therapy offers a promising solution to hard-to-treat chronic infections like those found in cystic fibrosis (CF) patients.
#antimicrobialresistance#lifesciences#biotechnology#AMR
https://t.co/2V3IyZ11W3
Researchers from the University of Pittsburgh have found a way to engineer custom T-cell therapies more efficiently. The researchers engineered T cells with receptors containing an enzyme called SNAPtag.
#biotechnology#lifesciences#celltherapy
https://t.co/n872BTqmeZ
UC Davis Health researchers are conducting a trial to investigate using duoCAR T-cell therapy to treat HIV. This is yet another example of CAR-T cell therapy branching out from oncology.
#biotechnology#lifesciences#celltherapy#HIV
https://t.co/tmve0Q9tI5
Kineticos has found that hiring top talent who can transition to engaged and competent employees is critical to success.
Click the link below to learn the steps for hiring the right employee.
#biotechnology#lifesciences
https://t.co/ZLERoWeA02
Verismo Therapeutics recently announced it had received Fast Track designation from the FDA for its investigational new drug, SynKIR-110, for treating patients with mesothelioma.
#biotechnology#lifesciences#celltherapy#cellandgenetherapy
https://t.co/cgTWqQDBIi
@immunebridge, an NK cell therapy biotech, recently closed out a $12M financing round led by M ventures and Insight Partners to help advance their novel NK Cell therapies.
#biotechnology#lifesciences#celltherapy
Click the link to learn more: https://t.co/Oz5Mu8WdCc
Click the link below to learn more about attracting, developing, and maintaining the right employees to propel your business into the future.
#biotechnology#lifesciences
https://t.co/cyxf1ulsEJ
CTRL Therapeutics, a company extracting circulating tumor-reactive lymphocytes (cTRLs) from blood to improve cell therapies, announced a $10M seed financing led by General Catalyst with participation from others.
#biotechnology#lifesciences#celltherapy
https://t.co/SYd343nCKw
Here we provide a guide on conducting a rigorous, blinded pricing study of current clients and prospects to uncover hidden areas where prices may be more sensitive and inelastic than currently perceived.
#biotechnology#lifesciences
https://t.co/8M3gG61d7s
RNA therapeutics could potentially remedy the problem of undruggable proteins. RNA can target any gene of interest by targeting a specific nucleotide sequence.
Click the link below to learn more.
#lifesciences#biotechnology#rnatherapeutics
https://t.co/MVBsiTk3mH
While most cell therapy research is oncology-focused, there has been an uptick in products targeting other therapeutic areas. Rinri Therapeutics focuses on hearing loss.
#biotechnology#lifesciences#celltherapy#cellandgenetherapy
https://t.co/V9g5lUMYME
Sonoma biotherapeutics and Regeneron announced a collaboration to combine their respective scientific expertise and technology platforms.
#biotechnology#lifesciences#celltherapy#cellandgenetherapy
https://t.co/7qtFXo5mwY https://t.co/a0mx9J3Qbv